Switch theme
Sign up to access all valuation multiples
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The Group is a well-located and scalable hospital that has delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs, and Private Medical Insurance providers. It treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.
2014
15.7K+
LTM Revenue $2.0B
LTM EBITDA $341M
$2.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Spire Healthcare Group has a last 12-month revenue of $2.0B and a last 12-month EBITDA of $341M.
In the most recent fiscal year, Spire Healthcare Group achieved revenue of $1.9B and an EBITDA of $321M.
Spire Healthcare Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Spire Healthcare Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.7B | $1.9B | XXX | XXX | XXX |
| Gross Profit | $693M | $804M | XXX | XXX | XXX |
| Gross Margin | 40% | 41% | XXX | XXX | XXX |
| EBITDA | $296M | $321M | XXX | XXX | XXX |
| EBITDA Margin | 17% | 16% | XXX | XXX | XXX |
| Net Profit | $11.1M | $35.2M | XXX | XXX | XXX |
| Net Margin | 1% | 2% | XXX | XXX | XXX |
| Net Debt | $322M | $407M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Spire Healthcare Group's stock price is GBP 2 (or $2).
Spire Healthcare Group has current market cap of GBP 712M (or $917M), and EV of GBP 1.9B (or $2.5B).
See Spire Healthcare Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.5B | $917M | XXX | XXX | XXX | XXX | $0.12 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Spire Healthcare Group has market cap of $917M and EV of $2.5B.
Spire Healthcare Group's trades at 1.3x LTM EV/Revenue multiple, and 7.4x LTM EBITDA.
Analysts estimate Spire Healthcare Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Spire Healthcare Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.5B | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 7.8x | XXX | XXX | XXX |
| P/E | 28.0x | XXX | XXX | XXX |
| P/E/Growth | 0.5x | XXX | XXX | XXX |
| EV/FCF | 15.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSpire Healthcare Group's NTM/LTM revenue growth is 6%
Spire Healthcare Group's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $44K for the same period.
Over next 12 months, Spire Healthcare Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Spire Healthcare Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Spire Healthcare Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 22% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $44K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 36% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Spire Healthcare Group acquired XXX companies to date.
Last acquisition by Spire Healthcare Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Spire Healthcare Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Spire Healthcare Group founded? | Spire Healthcare Group was founded in 2014. |
| Where is Spire Healthcare Group headquartered? | Spire Healthcare Group is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Spire Healthcare Group have? | As of today, Spire Healthcare Group has 15.7K+ employees. |
| Who is the CEO of Spire Healthcare Group? | Spire Healthcare Group's CEO is Mr. Justinian Joseph Ash. |
| Is Spire Healthcare Group publicy listed? | Yes, Spire Healthcare Group is a public company listed on LON. |
| What is the stock symbol of Spire Healthcare Group? | Spire Healthcare Group trades under SPI ticker. |
| When did Spire Healthcare Group go public? | Spire Healthcare Group went public in 2014. |
| Who are competitors of Spire Healthcare Group? | Similar companies to Spire Healthcare Group include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Spire Healthcare Group? | Spire Healthcare Group's current market cap is $917M |
| What is the current revenue of Spire Healthcare Group? | Spire Healthcare Group's last 12-month revenue is $2.0B. |
| What is the current EBITDA of Spire Healthcare Group? | Spire Healthcare Group's last 12-month EBITDA is $341M. |
| What is the current EV/Revenue multiple of Spire Healthcare Group? | Current revenue multiple of Spire Healthcare Group is 1.3x. |
| What is the current EV/EBITDA multiple of Spire Healthcare Group? | Current EBITDA multiple of Spire Healthcare Group is 7.4x. |
| What is the current revenue growth of Spire Healthcare Group? | Spire Healthcare Group revenue growth between 2023 and 2024 was 11%. |
| Is Spire Healthcare Group profitable? | Yes, Spire Healthcare Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
